ArticleProceedings of the National Academy of Sciences of the United States of America2011

Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.

Niv Papo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.